Meridian Bioscience
VIVO
#5216
Rank
A$2.24 B
Marketcap
A$51.14
Share price
0.00%
Change (1 day)
20.43%
Change (1 year)

Meridian Bioscience (VIVO) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : A$0.14 Billion

According to Meridian Bioscience's latest financial reports the company's total liabilities are A$0.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Meridian Bioscience - Total liabilities on balance sheet (from 2001 to 2022)

Total liabilities by year

Year Total liabilities Change
2022-09-30A$0.14 B-12%
2021-09-30A$0.16 B-23.66%
2020-09-30A$0.21 B10.43%
2019-09-30A$0.19 B89.43%
2018-09-30A$0.10 B2.87%
2017-09-30A$0.10 B-8.53%
2016-09-30A$0.11 B349.97%
2015-09-30A$24.83 M36.47%
2014-09-30A$18.19 M-21.85%
2013-09-30A$23.28 M29.41%
2012-09-30A$17.99 M3.3%
2011-09-30A$17.41 M-3.59%
2010-09-30A$18.06 M-13.28%
2009-09-30A$20.83 M-8.01%
2008-09-30A$22.64 M2.56%
2007-09-30A$22.08 M-37.07%
2006-09-30A$35.09 M-0.56%
2005-09-30A$35.29 M-30.48%
2004-09-30A$50.76 M-11.53%
2003-09-30A$57.37 M-23.39%
2002-09-30A$74.89 M-14.41%
2001-09-30A$87.5 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
QuidelOrtho
QDEL
A$5.47 B 3,728.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$78.08 B 54,475.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$44.30 B 30,866.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
A$5.96 B 4,070.63%๐Ÿ‡บ๐Ÿ‡ธ USA